RPRX
Royalty Pharma plc · Healthcare
EVP and CFO Terrance P. Coyne sold $1.6M of Royalty Pharma plc
Sold$1,627,534
$46.78Price
34,791Shares
−15%Stake
What RPRX did after the filing
- The stock from Thu, Mar 5 open, $46.83
- +6.3%
- S&P 500, same days
- +4.1%
Measured over 30 trading days, to the Apr 17 close.
Traded Mon, Mar 2. Filed Wed, Mar 4, 5:11 PM ET, after the close. Returns use the Mar 5 open and the Apr 17 close. Not investment advice.